Global Monoclonal Antibody Therapeutics Market Size & Trends Report Segmented by Source (Human, Humanized, Chimeric), Application (Oncology, Autoimmune Diseases, Infectious, Hematologic, Ophthalmology) End User & Regional Forecast to 2030

1. Introduction
   • Introduction
   • Market Scope
     • Market Definition
     • Segments Covered
     • Regional Segmentation
   • Research Timeframe
   • Currency Considered
   • Study Limitations
   • Stakeholders
   • List of Abbreviations
   • Key Conferences and Events (2025-2026)
2. Research Methodology
   • Secondary Research
   • Primary Research
   • Market Estimation
     • Bottom-Up Approach
     • Top-Down Approach
   • Market Forecasting
3. Executive Summary
   • Monoclonal Antibody Therapeutics Marke"4">
   • Market Overview
     • Market Dynamics
       • Drivers
         • Rising prevalence of chronic and autoimmune diseases
         • Advancements in the technologies related to drug engineering and development
         • Increased funding and investments into research and development
         • Approval of monoclonal antibody therapies
         • Increased acceptance of personalized medicine
         • Expanding applications of mAB therapy in various medical fields medicine
       • Restraints
         • High production and development costs
         • Stringent regulatory requirements
         • Patent expirations and biosimilar competition
         • Complexities in formulation and stability
       • Opportunities
         • Rising demand in emerging markets
         • Next-generation antibody platforms
         • Expansion into rare and orphan diseases
         • Combination therapies and ADCs
       • Key Market Trendse(AI) in drug discovery
       • Rise of bispecific antibodies
       • Biosimilar development and approvals
     • Unmet Market Needs
     • Industry Speaks
"5">
4. Global Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Source, USD Million
   • Introduction
   • Human Source
   • Humanized Source
   • Chimeric Source
   • Others
5. Global Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Application, USD Million
   • Introduction
   • Oncology
   • Autoimmune Diseases
   • Infectious Diseases
   • Hematologic Diseases
   • Ophthalmology
   • Others
6. Global Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By End User, USD Million
   • Introduction
   • Hospitals
   • Long-term Care Facilities
   • Others
7. Global Monoclonal Antibody Therapeutics Market Size & Forecan, USD Million
   • Introduction
   • North America Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Country, USD Million
     • US
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & Forecast, By End User (USD Million)
     • Canada
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & Forecast, By End User (USD Million)
   • Europe Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Country, USD Million
     • UK
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & ForecastMillion)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & Forecast, By End User (USD Million)
     • France
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & Forecast, By End User (USD Million)
     • Italy
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & Forecast, By End User (USD Million)
     • Spain
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & Forecast, By End User (USD Million)
     • Rest of Europe
       • Market Size & Forecast, By Source (US(USD Million)
   • Asia Pacific (APAC) Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Country, USD Million
     • China
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & Forecast, By End User (USD Million)
     • Japan
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & Forecast, By End User (USD Million)
     • India
       • Market Size & Forecast, By Source (USD Million)
       • Market Size & Forecast, By Application (USD Million)
       • Market Size & Forecast, By End User (USD Million)
     • Rest of Asia Pacific
       • Market Size & Forecast, By cast, By End User (USD Million)
   • Latin America (LATAM) Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), USD Million
     • Market Size & Forecast, By Source (USD Million)
     • Market Size & Forecast, By Application (USD Million)
     • Market Size & Forecast, By End User (USD Million)
   • Middle East & Africa (MEA) Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), USD Million
     • Market Size & Forecast, By Source (USD Million)
     • Market Size & Forecast, By Application (USD Million)
     • Market Size & Forecast, By End U"9">
     • Competitive Landscape
       • Key Players and their Competitive Positioning
         • Key Player Comparison
         • Segment-wise Player Mapping
         • Market Share Analysis (2024)
         • Company Categorization Matrix
           • Dominants/Leaders
           • New Entrants
           • Emerging Players
           • Innovative Players
         • Key Strategies Assessment, By Player (2022-2025)
           • New Product Launches
           • Partnerships, Agreements, & Collaborations
           • Mergers & Acquisitions
           • Geographic Expansion

10. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

• Hoffmann-La Roche Ltd
• AbbVie Inc.
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc
• Bristol-Myers Squibb (BMS)
• Amgen Inc.
• Novartis AG
• Eli Lilly and Company
• Sanofi
• AstraZeneca
• Other Prominent Players

Note: *Indicative list

**For listed companies